Risk evaluation and mitigation strategy updated for abortion pill, mifepristone; Potential PTSD therapy shows positive results; A host of HIV meds are to be discontinued in the next year; Weight-loss treatment gains expanded approval in pediatrics; Experts rank their best diets for a variety of categories.
Review finds that cutting omega-6 fatty acids that promote inflammation may be one promising strategy
In predominantly middle-aged cohort, higher omega-3 index linked to larger hippocampal volumes, better abstract reasoning
Agency says new definition is intended to both empower consumers to eat better and, potentially, foster a healthier food supply
Risk reduced for croup before age of three years
Approvals in psoriasis, hepatorenal syndrome, and neutropenia; novel therapy gains Priority Review for Rett Syndrome; and the effects of multivitamin supplementation assessed in cognitive function.
No association found for prescription of methotrexate with increased risk for COVID-19 or COVID-19-related death
Two studies show no significant difference in risk for COVID-19 or in four coprimary end points, including SARS-CoV-2, serious COVID-19
A serum 25(OH)D target of 30 to 60 ng/mL is safe, effective, and recommended for children and adolescents with type 1 diabetes
That flexibility was set to expire in late September. WIC accounts for about 50% of all the formula purchased in the US.
